Acadia

Drug makers leave the pain behind
EP Vantage
Fri, 08/26/22 - 10:26 am
painkillers
Acadia
Eli Lilly
Ampio Pharmaceuticals
Aptinyx
Eliem Therapeutics
Vertanical
Teva Pharamceutical
Regeneron
Vivozon
Vertex Pharmaceuticals
Biogen
Acadia, Neurocrine See Stock Price Bump After Quarterly Earnings
Xconomy
Fri, 08/2/19 - 12:55 pm
earnings
Acadia
Neurocrine
Acadia drops after hours on Phase III miss for schizophrenia
BioCentury
Mon, 07/22/19 - 11:08 pm
Acadia
Nuplazid
schizophrenia
clinical trials
Acadia Pharma Soars After FDA Investigation Clears Nuplazid of Additional Safety Problems
BioSpace
Fri, 09/21/18 - 11:25 am
Acadia
FDA
Nuplazid
Parkinson's Disease Psychosis
Under Fire for Risk/Efficacy Profile – Nuplazid Shows Potential for Treating Dementia-Related Psychosis
CP Wire
Mon, 09/10/18 - 11:43 am
Acadia
Nuplazid
pimavanserin
dementia-related psychosis
Parkinson's Disease Psychosis
Under Fire for Risk/Efficacy Profile – Nuplazid Shows Potential for Treating Dementia-Related Psychosis
Mon, 09/10/18 - 09:53 am
Acadia
Nuplazid
pimavanserin
dementia-related psychosis
Acadia can’t shake off its Nuplazid nightmare
EP Vantage
Tue, 07/10/18 - 04:59 pm
Acadia
FDA
Nuplazid
antipsychotic
The 3 Worst Biotech Stocks of 2018 (So Far)
Motley Fool
Sun, 07/8/18 - 12:35 pm
biotech
Prothena
Tesaro
Acadia
FDA re-examines safety of controversial new drug Nuplazid
CNN
Thu, 04/26/18 - 11:07 am
FDA
Nuplazid
congress
Parkinson's Disease
Acadia
CNN Article Details Deaths and Other Adverse Events Linked to Acadia's Nuplazid
CP Wire
Mon, 04/9/18 - 09:44 am
Acadia
Nuplazid
Parkinson's Disease Psychosis
CNN Article Details Deaths and Other Adverse Events Linked to Acadia's Nuplazid
Mon, 04/9/18 - 09:43 am
Acadia
Nuplazid
Parkinson's Disease Psychosis
4 Biotechs Ready to Kill the Market in 2018
BIospace
Sat, 12/30/17 - 10:41 am
biotech
Acadia
Sangamo Therapeutics
AnaptysBio
Sino Biopharmaceutical
Acadia launches Parkinson’s campaign to shine light on psychosis symptoms
Fierce Pharma
Mon, 11/27/17 - 10:16 am
Acadia
Parkinson's Disease
Parkinson's Disease Psychosis
drug ads
AstraZeneca targeting California-based Acadia Pharmaceuticals ($4.4bn)
GoInPharma
Sun, 09/10/17 - 11:34 am
AstraZeneca
M&A
Acadia
Drugmakers turn to tech to better demonstrate empathy
Medical Marketing and Media
Mon, 07/31/17 - 09:59 am
patients
physicians
empathy
Acadia
Alzheimer's disease psychosis drug clears mid-stage study -Acadia
Yahoo/Reuters
Tue, 12/20/16 - 12:29 pm
Acadia
Alzheimer's disease
pimavanserin
These 2 Biotechs Could Vanish by 2018
Motley Fool
Fri, 10/7/16 - 08:57 am
biotech
Acadia
MannKind
Nuplazid
Afrezza
10 Must-Know Biotech Stock Events to Close Out 2016
TheStreet.com
Fri, 09/9/16 - 09:04 pm
biotech
Eli Lilly
solanezumab
Biogen
aducanumab
Kite Pharma
KTE-C19
Bluebird Bio
LentiGlobin
Sarepta Therapeutics
eteplirsen
Ophthotech
Fovista
Bristol-Myers Squibb
Opdvio
Acadia
Nuplazid
Celgene
GED-301
Gilead Sciences
M&A
3 Biotech Stocks With Explosive Upside Potential
Motley Fool
Wed, 08/24/16 - 10:53 am
Acadia
Nuplazid
Radius Health
abaloparatide-SC
Sarepta Therapeutics
eteplirsen
These 3 Biotechs Have Automatic Demand
Motley Fool
Mon, 07/25/16 - 09:55 am
biotech
Acadia
Portola Pharmaceuticals
Ophthotech

Pages